RCUS
Arcus Biosciences Inc
26.40$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.9% | 92.9% | 94.2% | 94.9% | 95.3% | 79.3% | 79.3% | 75.9% | 88.3% | 88.4% | |
| 59.4% | 51.7% | 25.8% | 28.5% | 22.5% | 9.3% | 15.3% | 11.6% | 13.0% | 19.5% | |
| 90.1% | 92.2% | 93.3% | 92.7% | 94.3% | 31.4% | 75.0% | 69.3% | 85.0% | 86.1% | |
| 0.4% | 0.0% | 0.0% | 0.1% | 0.2% | 46.9% | 3.2% | 3.8% | 2.2% | 1.4% | |
| – | – | – | – | -0.9% | -47.9% | -12.8% | – | – | – | |
| 7.8% | 5.9% | 4.0% | 4.6% | 1.4% | 2.0% | 10.0% | – | – | – | |
| 9.3% | 19.2% | 14.5% | 19.3% | 35.0% | 47.1% | 51.2% | 57.8% | 57.8% | 44.6% | |
| 5.1% | 6.7% | 6.2% | 11.2% | 15.8% | 10.4% | 14.3% | 16.8% | 19.7% | 20.3% | |
| – | 1.6% | 2.2% | 4.7% | 0.4% | 0.3% | 0.2% | 1.0% | 1.0% | 1.1% | |
| 3.5% | 2.0% | 1.1% | 2.3% | 2.0% | 0.6% | 1.5% | 1.6% | 1.6% | 3.7% | |
| – | – | – | – | – | – | – | – | 4.2% | 8.7% | |
| 90.7% | 80.8% | 85.5% | 80.7% | 65.0% | 52.9% | 48.8% | 42.2% | 42.2% | 55.4% | |
| -18.4% | -38.4% | -44.7% | -101.1% | -42.5% | -17.3% | -40.3% | -77.5% | -98.4% | -130.4% | |
| 22.4% | 12.9% | 12.6% | 21.6% | 7.1% | 4.6% | 5.4% | 6.8% | 7.8% | 9.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.